Search research articles
Contact Us
Filters
Showing results (101-110 of 158) with videos related to
Page
of 16
Sort By:
Journal of the American College of Cardiology
|
June 18, 2013
Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults
Apoor S Gami, Eric J Olson, Win K Shen, et al.
Journal of Hospital Medicine
|
September 8, 2012
Clinical presentation and outcome of perioperative myocardial infarction in the very elderly following hip fracture surgery
Bhanu P Gupta, Jeanne M Huddleston, Lisa L Kirkland, et al.
European Heart Journal
|
November 4, 2022
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial
Kausik K Ray, David Kallend, Lawrence A Leiter, et al.
Journal of the American College of Cardiology
|
December 6, 2023
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials
R Scott Wright, Wolfgang Koenig, Ulf Landmesser, et al.
Journal of Critical Care
|
January 7, 2019
Severity of illness assessment with application of the APACHE IV predicted mortality and outcome trends analysis in an academic cardiac intensive care unit
Courtney E Bennett, R Scott Wright, Jacob Jentzer, et al.
Atherosclerosis
|
March 6, 2024
Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention
Kausik K Ray, Laura H Gunn, Lorena Garcia Conde, et al.
The Lancet. Diabetes & Endocrinology
|
January 9, 2023
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
Kausik K Ray, Roel P T Troquay, Frank L J Visseren, et al.
Mayo Clinic Proceedings
|
October 22, 2019
Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies
R Scott Wright, Michael G Collins, Robert M Stoekenbroek, et al.
Cardiovascular Research
|
May 16, 2024
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial
R Scott Wright, Frederick J Raal, Wolfgang Koenig, et al.
Annals of Internal Medicine
|
October 2, 2002
Acute myocardial infarction and renal dysfunction: a high-risk combination
R Scott Wright, Guy S Reeder, Charles A Herzog, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 158) with videos related to
Sort By:
Page
of 16
Journal of the American College of Cardiology
|
June 18, 2013
Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults
Apoor S Gami, Eric J Olson, Win K Shen, et al.
Journal of Hospital Medicine
|
September 8, 2012
Clinical presentation and outcome of perioperative myocardial infarction in the very elderly following hip fracture surgery
Bhanu P Gupta, Jeanne M Huddleston, Lisa L Kirkland, et al.
European Heart Journal
|
November 4, 2022
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial
Kausik K Ray, David Kallend, Lawrence A Leiter, et al.
Journal of the American College of Cardiology
|
December 6, 2023
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials
R Scott Wright, Wolfgang Koenig, Ulf Landmesser, et al.
Journal of Critical Care
|
January 7, 2019
Severity of illness assessment with application of the APACHE IV predicted mortality and outcome trends analysis in an academic cardiac intensive care unit
Courtney E Bennett, R Scott Wright, Jacob Jentzer, et al.
Atherosclerosis
|
March 6, 2024
Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention
Kausik K Ray, Laura H Gunn, Lorena Garcia Conde, et al.
The Lancet. Diabetes & Endocrinology
|
January 9, 2023
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
Kausik K Ray, Roel P T Troquay, Frank L J Visseren, et al.
Mayo Clinic Proceedings
|
October 22, 2019
Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies
R Scott Wright, Michael G Collins, Robert M Stoekenbroek, et al.
Cardiovascular Research
|
May 16, 2024
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial
R Scott Wright, Frederick J Raal, Wolfgang Koenig, et al.
Annals of Internal Medicine
|
October 2, 2002
Acute myocardial infarction and renal dysfunction: a high-risk combination
R Scott Wright, Guy S Reeder, Charles A Herzog, et al.
Page
of 16